SCHEMBL31565894

SCHEMBL31565894

NS(=O)(=O)NCC(=O)N1CCc2ccc(Oc3ccc(C(F)(F)F)cc3)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ LIPE Q05469 1/20 0.41
▸ ESR1 P03372 2/20 0.40
▸ ESR2 Q92731 2/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ GHSR Q92847 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.39
▸ MMP2 P08253 1/20 0.38
▸ MMP3 P08254 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP8 P22894 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ MMP14 P50281 1/20 0.38
▸ ABHD6 Q9BV23 1/20 0.37
▸ CPT2 P23786 1/20 0.37
▸ CPT1A P50416 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31565855 0.90 ALDH1A1 (0.45) NPC1RAB9AL3MBTL1ALDH1A1PKM
SCHEMBL31565916 0.88 ALDH1A1 (0.44) NPC1RAB9AL3MBTL1ALDH1A1PKM
SCHEMBL31566054 0.87 ALDH1A1 (0.46) NPC1RAB9AL3MBTL1ALDH1A1LIPE
SCHEMBL31565884 0.87 LIPE (0.43) L3MBTL1ALDH1A1LIPEESR1ESR2
SCHEMBL31565905 0.85 ALDH1A1 (0.45) NPC1RAB9AL3MBTL1ALDH1A1LIPE
SCHEMBL31565953 0.85 ALDH1A1 (0.43) L3MBTL1ALDH1A1LIPEESR1ESR2
SCHEMBL31566040 0.85 ALDH1A1 (0.46) NPC1RAB9AL3MBTL1ALDH1A1LIPE
SCHEMBL31565830 0.83 ALDH1A1 (0.47) RAB9AL3MBTL1ALDH1A1LIPEESR1
SCHEMBL31565889 0.83 ESR1 (0.47) L3MBTL1ALDH1A1LIPEESR1ESR2
SCHEMBL31565857 0.82 LIPE (0.45) L3MBTL1ALDH1A1LIPEESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR YAP1, YES1, LATS1 NPC1 1202/4885RAB9A 525/4885L3MBTL1 1076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback